enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. US FDA approves Elanco's skin disease treatment for dogs - AOL

   www.aol.com/news/us-fda-approves-elancos-skin...

   (Reuters) -The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the health regulator's website showed on Thursday, sending the company's ...

3. Oclacitinib - Wikipedia

   en.wikipedia.org/wiki/Oclacitinib

   Most of the other contraindications are avoiding cases where a potential side effect exacerbates a pre-existing condition: for example, because oclacitinib can cause lumps or tumors, it should not be used in dogs with cancer or a history of it; [15] because it is an immune system suppressant, it should not be used in dogs with serious infections.

4. Skin conditions in dogs: Symptoms, causes, and how to help - AOL

   www.aol.com/skin-conditions-dogs-symptoms-causes...

   Parasites: Treatment. Once an infestation begins, many pet parents struggle with how to get rid of fleas.Dr. MacMillan recommends using a vet-approved anti-parasite product, treating your home ...

5. Tigilanol tiglate - Wikipedia

   en.wikipedia.org/wiki/Tigilanol_tiglate

   Tigilanol tiglate (USAN; [1]), sold under the brand name Stelfonta is a medication used to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs). The FDA is also approving Stelfonta to treat non-metastatic MCTs located under the dog's skin (subcutaneous), in particular areas of a dog's leg. [2]

6. Polysulfated glycosaminoglycan - Wikipedia

   en.wikipedia.org/wiki/Polysulfated_glycosaminoglycan

   While it is currently only FDA-approved for dogs and horses, PSGAG is also used off-label to treat lameness in swine, as a chondroprotectant ("joint protector") or treatment of interstitial cystitis in cats, and to treat arthritis in rabbits. [1] [3] [9]

7. US FDA approves Elanco's treatment for parasitic infections ...

   www.aol.com/news/us-fda-approves-elancos...

   The drug, branded as Credelio Quattro, is a single, monthly chewable tablet for dogs eight weeks of age or older, the company said. The drug is approved for the treatment of flea and tick ...